Dicerna Posts Updated Data From Belcesiran Early-Stage Study For Genetic Liver Disease
Albireo's Rare Liver Disease Drug Bylvay Scores Back To Back Approvals In Europe, US
Albireo's Bylvay Scores European Nod For Rare Pediatric Liver Disease
Albireo's Bylvay Shows Further Evidence Of Sustained, Durable Effect In Pediatric Liver Disease Study
Liver Disease Recent News
Exclusive: Axcella Health Aims To Become The Standard Of Care
Immunic's IMU-838 Shows Promising Clinical Effect In Mid-Stage Liver Disease Study
Mallinkcrodt Is Betting On Ocerta Despite Doubts Around Its Liver Disease Drug
FDA Letter On Intercept Pharma Doesn't Include Black Box Warning Label...Yet
Will Intercept Stock Potential Be Blindsided By FDA Letter?
FDA Warning Letter Buckles Intercept Pharma Shares; Wells Fargo Downgrades
Here's Why Conatus Pharmaceuticals' Stock Surged 23%
Conatus Pharmaceuticals Surges 25% Following Positive Results In Phase 2 Study
Conatus Shares Move Higher On Industry Data
Market Wrap For January 9: All Eyes on Tomorrow's Job Report